Sign in

NCT07294274Recruiting

Construction and Clinical Validation Study of a Prediction Model for Depression After Ischemic Stroke

Source: ClinicalTrials.gov · Last updated 5 Feb 2026

Brief summary (registry, in English)

Post-stroke depression (PSD) is the most common neuropsychiatric disorder after a stroke, with an incidence rate of 20% to 60%. PSD is not only associated with higher mortality rates, poorer recovery, more obvious cognitive impairments, greater economic burdens, and lower quality of life, but also brings additional medical expenses and care pressure to families. Society also needs to bear higher medical costs. Currently, the early diagnosis of PSD is difficult, which may lead to poor prognosis after stroke. This study aims to utilize machine learning technology to integrate multi-dimensional indicators of patients with ischemic stroke, establish a risk prediction model for PSD, and assist in early, accurate, and individualized assessment of PSD risk in clinical practice.

Status (registry)
Recruiting
Study type
Observational
Enrollment
488 (estimated)
First submitted
27 Nov 2025
Start date
1 Nov 2025
Primary completion date
20 Jul 2026
Lead sponsor
Min Su
Diseases
Stroke
NCT number
NCT07294274

What you commit to

  • Study type: Observational
  • Planned participants: 488
  • From 1 Nov 2025 to the primary completion date, 20 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Confusion of consciousness,severe cognitive impairment, etc
  • Individuals with a history of depression, schizophrenia, bipolar disorder, etc;

Other

  • Individuals unable to participate in neuropsychological examinations due to hearing im pairments, lack of coordination, or neurological deficits, including se vere aphasia.

Who the study is looking for

  • Patients with acute ischemic stroke;
  • Admission within 7 days of symptom onset;
  • The patient and/or the family members sign a written informed consent form.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The First Affiliated Hospital of Chongqing Medical University
Coordinator of this site? Confirm its status
ChongqingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.